Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
3.880
+0.100 (2.65%)
At close: Oct 28, 2026, 4:00 PM EDT
3.908
+0.028 (0.73%)
Pre-market: Oct 29, 2026, 4:21 AM EDT
Bicycle Therapeutics Market Cap
Bicycle Therapeutics has a market cap or net worth of $271.57 million as of October 28, 2026. It is the 18,748th most valuable company in the world and the 3,306th biggest in the United States. Its market cap has decreased by 51.74% in one year.
Market Cap
271.57M
Enterprise Value
-223.82M
1-Year Change
-51.74%
Global Rank
Country Rank
#3,306 United States
Category
ChartMarket Cap Chart
Since May 23, 2019, Bicycle Therapeutics's market cap has increased from $212.36M to $271.57M, an increase of 27.88%. That is a compound annual growth rate of 3.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 271.57M | -44.70% |
| Dec 31, 2025 | 491.12M | -49.19% |
| Dec 31, 2024 | 966.64M | 26.03% |
| Dec 29, 2023 | 766.98M | -12.72% |
| Dec 30, 2022 | 878.81M | -50.89% |
| Dec 31, 2021 | 1.79B | 367.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 23, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Fulcrum Therapeutics | 278.48M |
| SAB Biotherapeutics | 272.96M |
| Rocket Pharmaceuticals | 267.85M |
| Vicore Pharma Holding AB | 266.64M |
| Q32 Bio | 258.10M |
| Century Therapeutics | 258.03M |
| Lineage Cell Therapeutics | 256.70M |
| Abeona Therapeutics | 253.90M |